Water-Soluble Cannabinoid and/or Terpene Extracts for Diverse Therapeutic Applications

Publication ID: 24-11857589_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Water-Soluble Cannabinoid and/or Terpene Extracts for Diverse Therapeutic Applications,” Published Technical Disclosure No. 24-11857589_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857589_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,589.

Summary of the Inventive Concept

This inventive concept leverages the core technology of water-soluble, powdered cannabinoid and/or terpene extracts to address various unmet medical needs across multiple industries, including dermatology, veterinary care, sleep disorders, gut health, and women's health.

Background and Problem Solved

The original patent disclosed a novel method for creating water-soluble, powdered cannabinoid and/or terpene extracts. However, the patent's scope was limited to specific applications. This inventive concept addresses the need for expanding the technology's reach to tackle diverse therapeutic challenges, such as skin conditions, anxiety in pets, sleep quality, gut inflammation, and menstrual cramps.

Detailed Description of the Inventive Concept

The inventive concept involves the application of water-soluble, powdered cannabinoid and/or terpene extracts to various industries, including dermatology, veterinary care, sleep disorders, gut health, and women's health. The extracts are complexed with a cyclodextrin and emulsified with a combination of maltodextrin and acacia, enabling their use in diverse formulations, such as topical creams, treats, capsules, tablets, and transdermal patches. These formulations can provide relief from inflammation, anxiety, insomnia, gut inflammation, and menstrual cramps, among other benefits.

Novelty and Inventive Step

The inventive concept's novelty lies in the expansion of the original technology to address previously unconsidered therapeutic applications, demonstrating a non-obvious and innovative approach to leveraging the core technology. The new claims introduce unexpected and valuable uses for the water-soluble, powdered cannabinoid and/or terpene extracts.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may involve different formulations, such as nasal sprays, suppositories, or injectables, to further expand the technology's reach. Variations may include the use of different cyclodextrins, emulsifiers, or additives to optimize the extracts' performance in specific applications.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across multiple industries, including pharmaceuticals, veterinary care, cosmetics, and nutraceuticals. The target markets include patients suffering from skin conditions, pet owners seeking anxiety relief for their pets, individuals struggling with sleep disorders, and those experiencing gut inflammation or menstrual cramps. The market size is substantial, with potential revenue streams from licensing, partnerships, and product sales.

CPC Classifications

SectionClassGroup
A A61 A61K36/185
A A61 A61K9/107
A A61 A61K47/02
A A61 A61K47/36
A A61 A61K47/40
A A61 A61K47/44

Original Patent Information

Patent NumberUS 11,857,589
TitleWater-soluble, powdered cannabinoid and/or terpene extract
Assignee(s)MEDPHARM HOLDINGS, LLC